Close Menu

360Dx

The company reported performance changes that led to the product recall and said it is pursuing eventual FDA clearance for the devices.

An international group of researchers aim to develop an approach that may be able to diagnose multiple conditions, including pneumonia, tuberculosis, sepsis, with one blood sample.

The team anticipates launching its first clinical diagnostic assay, which will detect targeted, low-frequency genetic mutations in lung cancer, in 2021.

The diagnostic firms were the final companies in the coverage universe of 360Dx to present at the annual conference.